Archive for July 2017

Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-stocks-down3.jpg" NAME"Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study" ALT"Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study"July 31, 2017By <A HREF"http://www.biospace.com/news_subject_all_results.aspx?CatagoryId40274"… Source: BioSpace

Read More

FDA Calls AstraZeneca PLC and MedImmune???s Imfinzi a Breakthrough

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-astrazeneca-sean-bohen.jpg" NAME"FDA Calls AstraZeneca and MedImmunes Imfinzi a Breakthrough" ALT"FDA Calls AstraZeneca and MedImmunes Imfinzi a Breakthrough"July 31, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace

Read More

District Court Issues Permanent Injunction to Seller of Unapproved Dermatological Drugs

The U.S. District Court for the Eastern District of Tennessee entered a permanent injunction against Crown Laboratories of Johnson City and its CEO, Jeffrey Bedard, after accusations of distributing unapproved and misbranded drugs. The company’s products, which include urea creams and lotions intended to treat dermatological problems, were sold and distributed without FDA approval or…

Read More

Senate’s ACA Repeal Blocked by Murkowski, Collins, McCain

Pharmaceutical and medical device companies will not get tax breaks after the Republican effort to repeal the Affordable Care Act came to a halt in the Senate early Friday morning, with nays from Sens. Lisa Murkowski (R-Alaska), Susan Collins (R-Maine) and John McCain (R-Ariz.). Source: Drug Industry Daily

Read More

CMOs Cringe as GlaxoSmithKline Will be Cutting Its Use by 25%

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×400-glaxosmithkline.jpg" NAME"CMOs Cringe as GlaxoSmithKline Will be Cutting Its Use by 25%" ALT"CMOs Cringe as GlaxoSmithKline Will be Cutting Its Use by 25%"July 28, 2017By Mark Terry, BioSpace.com Breaking News Staff<BR… Source: BioSpace

Read More